Skip to content

McMinn Rachel

Reporting owner on Forms 3, 4 and 5, CIK 1606302.

McMinn Rachel reported on 1 issuer in 1 filing, the latest a Form 4 filed 2026-10-02.

Issuers

IssuerRoles in the latest filingFilingsLast filed
Neurogene Inc. CIK 1404644director, officer (Chief Executive Officer)12026-10-02

Transactions and holdings

Every row of the person's Forms 3, 4 and 5, newest first, with the price and the amount owned after the row as filed.

SecurityDateCodeSharesPriceOwned afterFiling
Neurogene Inc. Common Stock2026-09-22M exercised+756$25.321,345,063Form 4
Neurogene Inc. Stock Option (Right to Buy), derivative2026-09-22M exercised-756$00Form 4

Filings

The person's Forms 3, 4 and 5, and any 13D or 13G naming it.

FilingSubjectFiledAcceptedIngested
Form 4 0001606302-26-000007 Neurogene Inc.2026-10-02